CA Patent

CA2707449A1 — Compounds and methods for enzyme-mediated tumor imaging and therapy

Assigned to Harvard University · Expires 2009-06-12 · 17y expired

What this patent protects

The invention provides methods and compositions, e.g., for tumor imaging and therapy.

USPTO Abstract

The invention provides methods and compositions, e.g., for tumor imaging and therapy.

Drugs covered by this patent

belumosudil-mesylate (BELUMOSUDIL MESYLATE)

Patent Metadata

Patent number: CA2707449A1
Jurisdiction: CA
Classification: —
Expires: 2009-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Harvard University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.